CoLabs launches $397,074 deep tech pre-accelerator in Melbourne

CoLabs has launched Kinesis, a lab-embedded pre-accelerator in Melbourne backed by $397,074 through LaunchVic to help deep tech founders validate demand before building. The program targets Applied Biology, AI-enabled and other deep tech ventures across health, agriculture, manufacturing and sustainability.

Why it matters: - Kinesis is designed to reduce a common deep tech failure mode: building products before proving customers want them. - The program gives founders lab access, industry feedback and commercialisation support earlier in the process, when pivots are still possible. - CoLabs is betting that better validation can save years of development time and significant capital.

What happened: - CoLabs launched Kinesis, a new lab-embedded pre-accelerator for founders in Applied Biology, AI-enabled and other deep tech ventures. - LaunchVic is backing the program with $397,074 through its Grants for Pre-Accelerators program. - Applications are open to founders, researchers and emerging startup teams. - CoLabs is also recruiting industry partners, manufacturers, research organisations, investors and corporate sponsors.

The details: - Kinesis will support ventures in health, agriculture, advanced manufacturing and sustainability. - Founders will work inside CoLabs' PC2 laboratory and co-working facilities. - The program uses three phases adapted from the Stanford Biodesign methodology: Identify, Invent and Implement. - Teams will spend the opening weeks testing a real-world need, sizing the market and assessing competitors before building a minimum viable platform. - Strategic partners, manufacturers, industry validators, buyers and downstream investors will be involved early. - Participating teams receive access to CoLabs' PC2 laboratories, specialist scientific equipment, co-working space and commercialisation experts. - CoLabs takes no equity. - Teams may receive up to $5,000 in non-dilutive funding for prototyping and early technical validation. - Graduated ventures can keep lab access and milestone-based support for up to 12 months. - Across two cohorts running through early 2028, Kinesis aims to support at least 17 startup teams and graduate at least 15 ventures. - The program will host two investor and industry demo days and four public ecosystem events. - The delivery team includes experience from Melbourne Biodesign, Perth Biodesign, ANDHealth, StartupBootcamp and At The Frontier. - Program information is available here.

Between the lines: - CB Insights' 2026 analysis of 431 failed venture-backed startups found that 43% cited poor product-market fit as a root cause of failure. - That backdrop helps explain why deep tech programs are putting more emphasis on need-finding, customer discovery and market validation before heavy build costs begin. - Andrew Gray, Executive Director of CoLabs, said product-market fit is the underlying issue behind many startup failures and that Kinesis is built to address that stage early. - Eldin Rostom, Entrepreneur in Residence at Kinesis and founder of respiratory biology company Diag-Nose.io, said founders can spend years building technically strong products that no one will buy if customer input comes too late. - Rod Bristow, incoming CEO of Innovation Victoria, said programs like Kinesis help founders make better decisions earlier and create stronger ventures for Victoria. - CoLabs says it has supported more than 35 ventures since 2020, and those companies have collectively raised over $300 million.

What's next: - Kinesis will run across two cohorts through early 2028. - LaunchVic support continues for the program, while responsibility for the Grants for Pre-Accelerators program will later transition to Breakthrough Victoria under planned Victorian Government innovation funding reforms. - CoLabs is still seeking industry participation, sponsorship and validation partners to shape the program and connect with early-stage deep tech teams.

The bottom line: - CoLabs is trying to move deep tech founders from lab promise to market proof before they spend years and money building the wrong thing.